Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detection

Autores
Sookoian, Silvia Cristina; Pirola, Carlos José
Año de publicación
2009
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Proper screening for cardiovascular risk and fatty liver disease will be critical in primary prevention and in the treatment of existing but undiagnosed cardiovascular and liver disease in young individuals. Accordingly, NAFLD may contribute to the systemic inflammation and insulin resistance, which are critical events in the pathophysiology of the cardiometabolic syndrome. In such cases, type II angiotensin receptor blockers are promising therapeutics agents.
Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina
Fil: Pirola, Carlos José. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Materia
SHIFT WORK
ATHEROSCLEROSIS
CLINICAL RECOMMENDATIONS
FATTY LIVER
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/103757
Acceder
id CONICETDig_72d8086aa3e055bd623b8c6011f98fae
oai_identifier_str oai:ri.conicet.gov.ar:11336/103757
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detectionSookoian, Silvia CristinaPirola, Carlos JoséSHIFT WORKATHEROSCLEROSISCLINICAL RECOMMENDATIONSFATTY LIVERhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Proper screening for cardiovascular risk and fatty liver disease will be critical in primary prevention and in the treatment of existing but undiagnosed cardiovascular and liver disease in young individuals. Accordingly, NAFLD may contribute to the systemic inflammation and insulin resistance, which are critical events in the pathophysiology of the cardiometabolic syndrome. In such cases, type II angiotensin receptor blockers are promising therapeutics agents.Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; ArgentinaFil: Pirola, Carlos José. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaElsevier Ireland2009-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/103757Sookoian, Silvia Cristina; Pirola, Carlos José; Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detection; Elsevier Ireland; Atherosclerosis; 207; 2; 12-2009; 346-3470021-9150CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.atherosclerosis.2009.06.008info:eu-repo/semantics/altIdentifier/url/https://www.atherosclerosis-journal.com/article/S0021-9150(09)00440-7/fulltextinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:02:03Zoai:ri.conicet.gov.ar:11336/103757instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:02:03.722CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detection
title Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detection
spellingShingle Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detection
Sookoian, Silvia Cristina
SHIFT WORK
ATHEROSCLEROSIS
CLINICAL RECOMMENDATIONS
FATTY LIVER
title_short Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detection
title_full Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detection
title_fullStr Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detection
title_full_unstemmed Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detection
title_sort Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detection
dc.creator.none.fl_str_mv Sookoian, Silvia Cristina
Pirola, Carlos José
author Sookoian, Silvia Cristina
author_facet Sookoian, Silvia Cristina
Pirola, Carlos José
author_role author
author2 Pirola, Carlos José
author2_role author
dc.subject.none.fl_str_mv SHIFT WORK
ATHEROSCLEROSIS
CLINICAL RECOMMENDATIONS
FATTY LIVER
topic SHIFT WORK
ATHEROSCLEROSIS
CLINICAL RECOMMENDATIONS
FATTY LIVER
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Proper screening for cardiovascular risk and fatty liver disease will be critical in primary prevention and in the treatment of existing but undiagnosed cardiovascular and liver disease in young individuals. Accordingly, NAFLD may contribute to the systemic inflammation and insulin resistance, which are critical events in the pathophysiology of the cardiometabolic syndrome. In such cases, type II angiotensin receptor blockers are promising therapeutics agents.
Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina
Fil: Pirola, Carlos José. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
description Proper screening for cardiovascular risk and fatty liver disease will be critical in primary prevention and in the treatment of existing but undiagnosed cardiovascular and liver disease in young individuals. Accordingly, NAFLD may contribute to the systemic inflammation and insulin resistance, which are critical events in the pathophysiology of the cardiometabolic syndrome. In such cases, type II angiotensin receptor blockers are promising therapeutics agents.
publishDate 2009
dc.date.none.fl_str_mv 2009-12
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/103757
Sookoian, Silvia Cristina; Pirola, Carlos José; Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detection; Elsevier Ireland; Atherosclerosis; 207; 2; 12-2009; 346-347
0021-9150
CONICET Digital
CONICET
url http://hdl.handle.net/11336/103757
identifier_str_mv Sookoian, Silvia Cristina; Pirola, Carlos José; Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detection; Elsevier Ireland; Atherosclerosis; 207; 2; 12-2009; 346-347
0021-9150
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1016/j.atherosclerosis.2009.06.008
info:eu-repo/semantics/altIdentifier/url/https://www.atherosclerosis-journal.com/article/S0021-9150(09)00440-7/fulltext
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier Ireland
publisher.none.fl_str_mv Elsevier Ireland
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269734371852288
score 13.13397

Publicaciones similares